Expression of sirtuin in hepatocellular carcinoma and its clinical significance
10.3760/cma.j.issn.1007-8118.2013.10.019
- VernacularTitle:Sirtuin家族在肝细胞癌中的表达及临床意义
- Author:
Chong HAO
;
Lixin WEI
- Publication Type:Journal Article
- Keywords:
SIRT1;
Hepatocellular carcinoma;
Deacetylase;
p53
- From:Chinese Journal of Hepatobiliary Surgery
2013;19(10):789-793
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) development is closely related to overexpression of tumor promoters or down-regulation of tumor suppressors.The mammalian sirtuin family was found to be a nicotinamide adenosine dinucleotide (NAD/NADH)-dependent histone deacetylase (HDAC),which implicated in the regulation of critical biological processes through deacetylation modifying on histone and nonhistone.SIRT1 can regulate metabolism,aging,inflammation and cancer progression.In particular,more and more evidence proves that SIRT1 can act as a tumor promot er in hepatocellular carcinoma through deacetylation on tumor suppressors.On the other hand,SIRT1 can strongly suppress metabolic syndrome-associated liver cancer in the mouse model.This review will discuss the expression of sirtuin family member in liver cancer and its clinical significance.
